Accesso libero

The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus

Douglas Edward Barre

Barre, Douglas Edward

e

Kazimiera Amelia Mizier-Barre

Mizier-Barre, Kazimiera Amelia

08 mag 2020

The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus's Cover Image

Endocrine Regulations

Volume 54 (2020): Numero 2 (Aprile 2020)

INFORMAZIONI SU QUESTO ARTICOLO

Articolo precedente

Articolo Successivo

Cita

CONDIVIDI

Scarica la copertina

Pubblicato online: 08 mag 2020

Pagine: 137 - 155

DOI: https://doi.org/10.2478/enr-2020-0017

Parole chiave
cinnamic acids and related compounds, type 2 diabetes mellitus, central obesity, hyperglycemia, hypertension, dyslipidemia, pro-thrombosis, oxidation and inflammation

© 2020 Douglas Edward Barre et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Barre, Douglas Edward

Department of Health Sciences, Cape Breton UniversitySydney, Canada

Mizier-Barre, Kazimiera Amelia

Department of Health Sciences, Cape Breton UniversitySydney, Canada

Lingua:: Inglese

Frequenza di pubblicazione:: 1 volte all'anno
Argomenti della rivista:: Scienze biologiche, Biologia molecolare, Neurobiologia, Medicina, Scienze medicali di base, Scienze medicali di base, altro, Medicina clinica, Medicina interna, Endocrinologia, Diabetologia

Feed RSS della rivista